Table 3 Summary of main findings
➢ A significant increase in NGAL concentration post-FURS for the management of nephrolithiasis (p = 0.034). | |
➢ No significant differences were seen in Cystatin C, MPO or PCT concentrations post-FURS, for the management of nephrolithiasis (p > 0.05) |